Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07186725Not ApplicableRecruiting

Home-based Under Mattress Monitor for OSA

Role: lead

NCT07103941Not ApplicableRecruiting

IOA Preventing Occlusal Changes With MAD Use

Role: lead

NCT03848143Phase 2Completed

Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain

Role: lead

NCT05139303Not ApplicableCompleted

Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.

Role: lead

All 4 trials loaded